Table 5.

Relative risk of other common malignancies in individuals with nonmedullary thyroid cancer–affected first-degree relatives vs the general population of Taiwan

With affected relativesGeneral population
SexNo.Prevalence, ‰No.Prevalence, ‰Adjusted RRa (95% CI)
Breast cancerMale20.054990.042.05 (0.52-8.06)
Female2887.98129 89710.931.15 (1.02-1.28)b
All2903.93130 3965.501.15 (1.03-1.29)b
Colorectal cancerMale1193.1659 4465.031.01 (0.84-1.20)
Female1313.6348 8594.111.37 (1.15-1.62)b
All2503.39108 3054.571.17 (1.03-1.32)b
Lung cancerMale691.8322 1841.881.59 (1.26-2.01)b
Female661.8321 3511.801.55 (1.22-1.97)b
All1351.8243 5351.841.56 (1.32-1.85)b
Liver cancerMale751.9933 7262.861.09 (0.87-1.37)
Female330.9114 6811.241.19 (0.85-1.67)
All1081.4648 4072.041.13 (0.94-1.36)
Leukemia and lymphomaMale621.6518 5151.571.31 (1.02-1.67)b
Female451.2515 7781.331.17 (0.86-1.56)
All1071.4534 2931.451.24 (1.03-1.50)b
With affected relativesGeneral population
SexNo.Prevalence, ‰No.Prevalence, ‰Adjusted RRa (95% CI)
Breast cancerMale20.054990.042.05 (0.52-8.06)
Female2887.98129 89710.931.15 (1.02-1.28)b
All2903.93130 3965.501.15 (1.03-1.29)b
Colorectal cancerMale1193.1659 4465.031.01 (0.84-1.20)
Female1313.6348 8594.111.37 (1.15-1.62)b
All2503.39108 3054.571.17 (1.03-1.32)b
Lung cancerMale691.8322 1841.881.59 (1.26-2.01)b
Female661.8321 3511.801.55 (1.22-1.97)b
All1351.8243 5351.841.56 (1.32-1.85)b
Liver cancerMale751.9933 7262.861.09 (0.87-1.37)
Female330.9114 6811.241.19 (0.85-1.67)
All1081.4648 4072.041.13 (0.94-1.36)
Leukemia and lymphomaMale621.6518 5151.571.31 (1.02-1.67)b
Female451.2515 7781.331.17 (0.86-1.56)
All1071.4534 2931.451.24 (1.03-1.50)b

Abbreviation: RR, relative risk.

aAdjusted for age, sex, place of residence, quintiles of income level, occupation, and family size.

bP less than .05.

Table 5.

Relative risk of other common malignancies in individuals with nonmedullary thyroid cancer–affected first-degree relatives vs the general population of Taiwan

With affected relativesGeneral population
SexNo.Prevalence, ‰No.Prevalence, ‰Adjusted RRa (95% CI)
Breast cancerMale20.054990.042.05 (0.52-8.06)
Female2887.98129 89710.931.15 (1.02-1.28)b
All2903.93130 3965.501.15 (1.03-1.29)b
Colorectal cancerMale1193.1659 4465.031.01 (0.84-1.20)
Female1313.6348 8594.111.37 (1.15-1.62)b
All2503.39108 3054.571.17 (1.03-1.32)b
Lung cancerMale691.8322 1841.881.59 (1.26-2.01)b
Female661.8321 3511.801.55 (1.22-1.97)b
All1351.8243 5351.841.56 (1.32-1.85)b
Liver cancerMale751.9933 7262.861.09 (0.87-1.37)
Female330.9114 6811.241.19 (0.85-1.67)
All1081.4648 4072.041.13 (0.94-1.36)
Leukemia and lymphomaMale621.6518 5151.571.31 (1.02-1.67)b
Female451.2515 7781.331.17 (0.86-1.56)
All1071.4534 2931.451.24 (1.03-1.50)b
With affected relativesGeneral population
SexNo.Prevalence, ‰No.Prevalence, ‰Adjusted RRa (95% CI)
Breast cancerMale20.054990.042.05 (0.52-8.06)
Female2887.98129 89710.931.15 (1.02-1.28)b
All2903.93130 3965.501.15 (1.03-1.29)b
Colorectal cancerMale1193.1659 4465.031.01 (0.84-1.20)
Female1313.6348 8594.111.37 (1.15-1.62)b
All2503.39108 3054.571.17 (1.03-1.32)b
Lung cancerMale691.8322 1841.881.59 (1.26-2.01)b
Female661.8321 3511.801.55 (1.22-1.97)b
All1351.8243 5351.841.56 (1.32-1.85)b
Liver cancerMale751.9933 7262.861.09 (0.87-1.37)
Female330.9114 6811.241.19 (0.85-1.67)
All1081.4648 4072.041.13 (0.94-1.36)
Leukemia and lymphomaMale621.6518 5151.571.31 (1.02-1.67)b
Female451.2515 7781.331.17 (0.86-1.56)
All1071.4534 2931.451.24 (1.03-1.50)b

Abbreviation: RR, relative risk.

aAdjusted for age, sex, place of residence, quintiles of income level, occupation, and family size.

bP less than .05.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close